LIMD2 Regulates Key Steps of Metastasis Cascade in Papillary Thyroid Cancer Cells via MAPK Crosstalk

Although papillary thyroid carcinoma (PTC) has a good prognosis, 20–90% of patients show metastasis to regional lymph nodes and 10–15% of patients show metastasis to distant sites. Metastatic disease represents the main clinical challenge that impacts survival rate. We previously showed that LIMD2 was a novel metastasis-associated gene. In this study, to interrogate the role of LIMD2 in cancer invasion and metastasis, we used CRISPR-mediated knockout (KO) of LIMD2 in PTC cells (BCPAP and TPC1). Western blot and high-content screening (HCS) analysis confirmed functional KO of LIMD2. LIMD2 KO reduced in vitro invasion and migration. Ultrastructural analyses showed that cell polarity and mitochondria function and morphology were restored in LIMD2 KO cells. To unveil the signals supervising these phenotypic changes, we employed phospho-protein array. Several members of the MAPK superfamily showed robust reduction in phosphorylation. A Venn diagram displayed the overlap of kinases with reduced phosphorylation in both cell lines and showed that they were able to initiate or sustain the epithelial-mesenchymal transition (EMT) and DNA damage checkpoint. Flow cytometry and HCS validation analyses further corroborated the phospho-protein array data. Collectively, our findings show that LIMD2 enhances phosphorylation of kinases associated with EMT and invasion. Through cooperation with different kinases, it contributes to the increased genomic instability that ultimately promotes PTC progression.

[1]  Gong Yang,et al.  The crosstalk between STAT3 and p53/RAS signaling controls cancer cell metastasis and cisplatin resistance via the Slug/MAPK/PI3K/AKT-mediated regulation of EMT and autophagy , 2019, Oncogenesis.

[2]  S. Qin,et al.  Overexpression of LIMD2 promotes the progression of non-small cell lung cancer. , 2019, Oncology letters.

[3]  C. Korch,et al.  Comprehensive Genetic Characterization of Human Thyroid Cancer Cell Lines: A Validated Panel for Preclinical Studies , 2019, Clinical Cancer Research.

[4]  Qing‐Yu He,et al.  Significance of integrin-linked kinase (ILK) in tumorigenesis and its potential implication as a biomarker and therapeutic target for human cancer. , 2019, American journal of cancer research.

[5]  M. Schlumberger,et al.  Occult Contralateral Lateral Lymph Node Metastases in Unilateral N1b Papillary Thyroid Carcinoma , 2018, World Journal of Surgery.

[6]  Fei Wang,et al.  LIMD2 targeted by miR‑34a promotes the proliferation and invasion of non‑small cell lung cancer cells. , 2018, Molecular medicine reports.

[7]  B. Jakovljević,et al.  Lymph Node Metastases Papillary Thyroid Carcinoma and their Importance in Recurrence of Disease , 2018, Medical archives.

[8]  F. Rauscher,et al.  LIMD2 Is Overexpressed in BRAF V600E-Positive Papillary Thyroid Carcinomas and Matched Lymph Node Metastases , 2018, Endocrine Pathology.

[9]  J. Cerutti,et al.  Novel biotechnological opportunities in thyroid cancer metastasis based on LIMD2 differential expression , 2018 .

[10]  J. Cerutti,et al.  ABI3, a component of the WAVE2 complex, is potentially regulated by PI3K/AKT pathway , 2017, Oncotarget.

[11]  Nancy D Perrier,et al.  Updated American Joint Committee on Cancer/Tumor-Node-Metastasis Staging System for Differentiated and Anaplastic Thyroid Cancer (Eighth Edition): What Changed and Why? , 2017, Thyroid : official journal of the American Thyroid Association.

[12]  Chen Huang,et al.  Regulation of EMT by STAT3 in gastrointestinal cancer (Review). , 2017, International journal of oncology.

[13]  Kevin W. Eliceiri,et al.  ImageJ2: ImageJ for the next generation of scientific image data , 2017, BMC Bioinformatics.

[14]  Kaliszewski,et al.  American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer : The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer , 2017 .

[15]  S. Mandel,et al.  2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. , 2009, Thyroid : official journal of the American Thyroid Association.

[16]  M. Saji,et al.  Integrin-linked kinase affects signaling pathways and migration in thyroid cancer cells and is a potential therapeutic target. , 2016, Surgery.

[17]  R. Franco,et al.  Mast cells induce epithelial-to-mesenchymal transition and stem cell features in human thyroid cancer cells through an IL-8–Akt–Slug pathway , 2015, Oncogene.

[18]  Anders Larsson,et al.  AliView: a fast and lightweight alignment viewer and editor for large datasets , 2014, Bioinform..

[19]  Qihong Huang,et al.  LIMD2 is a small LIM-only protein overexpressed in metastatic lesions that regulates cell motility and tumor progression by directly binding to and activating the integrin-linked kinase. , 2014, Cancer research.

[20]  Xuelin Huang,et al.  An improvement of the 2ˆ(-delta delta CT) method for quantitative real-time polymerase chain reaction data analysis. , 2013, Biostatistics, bioinformatics and biomathematics.

[21]  S. Bhatia,et al.  Mitochondrial localization and the persistent migration of epithelial cancer cells. , 2013, Biophysical journal.

[22]  R. Lloyd,et al.  Expression of epithelial-mesenchymal transition regulators SNAI2 and TWIST1 in thyroid carcinomas , 2013, Modern Pathology.

[23]  A. Baxevanis,et al.  The Diversification of the LIM Superclass at the Base of the Metazoa Increased Subcellular Complexity and Promoted Multicellular Specialization , 2012, PloS one.

[24]  Alexandru Almasan,et al.  Histone H2AX phosphorylation: a marker for DNA damage. , 2012, Methods in molecular biology.

[25]  R. Maestro,et al.  Overexpression of TWIST2 correlates with poor prognosis in Head and Neck Squamous Cell Carcinomas , 2011, OncoTarget.

[26]  J. Cerutti,et al.  The RET p.G533C mutation confers predisposition to multiple endocrine neoplasia type 2A in a Brazilian kindred and is able to induce a malignant phenotype in vitro and in vivo. , 2011, Thyroid : official journal of the American Thyroid Association.

[27]  D. Meek,et al.  Phosphorylation of serine 392 in p53 is a common and integral event during p53 induction by diverse stimuli. , 2010, Cellular signalling.

[28]  T. Hupp,et al.  The regulation of p53 by phosphorylation: a model for how distinct signals integrate into the p53 pathway , 2009, Aging.

[29]  B. Olsen,et al.  Snail and Slug promote epithelial-mesenchymal transition through beta-catenin-T-cell factor-4-dependent expression of transforming growth factor-beta3. , 2008, Molecular biology of the cell.

[30]  G. Riggins,et al.  Molecular profiling of matched samples identifies biomarkers of papillary thyroid carcinoma lymph node metastasis. , 2007, Cancer research.

[31]  A. Chrisoulidou,et al.  Cerebellar metastasis as first metastasis from papillary thyroid carcinoma. , 2005, Endocrine journal.

[32]  Conrad C. Huang,et al.  UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..

[33]  F. Hirsch,et al.  The E-cadherin cell-cell adhesion complex and lung cancer invasion, metastasis, and prognosis. , 2002, Lung cancer.

[34]  E. Fearon,et al.  The SLUG zinc-finger protein represses E-cadherin in breast cancer. , 2002, Cancer research.

[35]  Eric R. Fearon,et al.  Advances in Brief The SLUG Zinc-Finger Protein Represses E-Cadherin in Breast Cancer 1 , 2002 .

[36]  M. Ranney,et al.  Beyond the bedside: Clinicians as guardians of public health, medicine and science , 2020, The American Journal of Emergency Medicine.